At the news
? NEUTRALIMPACT 2/10 144 filed Jun 1, 2026 at 16:04 ET
Director Saira Ramasastry filed a Form 144 notice of intent to sell 3,977 shares of Mirum Pharmaceuticals common stock, valued at approximately $397,700 based on the filing date. This is a modest sale relative to the company's $6.2B market cap and follows a pattern of regular monthly sales by the director (2,000 shares each in March, April, and May 2026). The filing is routine and does not signal material insider concern.
- Director Saira Ramasastry filed Form 144 to sell 3,977 shares of MIRM common stock.
- Estimated sale value is approximately $397,700 based on filing date.
- Ramasastry has sold 2,000 shares per month in March, April, and May 2026, suggesting a pre-planned trading pattern.
- The sale represents a tiny fraction of the company's $6.2B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access